TrialClinical drug investigation2015

A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers.

Ramesh Boinpally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.